Tuesday 13 October 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
68.86
1.84
+2.75%
Follow CNC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(21.85%) | (28.69%) | (26.03%) | (20.35%) | |
Piotroski F-Score |
4 | 5 | 6 | 6 | |
| (6.43%) | (8.38%) | (7.66%) | (6.02%) | ||
ROIC |
(18.39%) | (27.84%) | (32.27%) | (30.17%) | |
Return on Tangible Assets |
(94.58%) | (117.31%) | (91.61%) | (63.31%) | |
Average Days of Receivables |
45.38 | 33.93 | 35.79 | 32.51 | |
Free Cash Flow per Share |
6.83 | 8.76 | 14.45 | 18.13 | |
Free Cash Flow |
3,356.00 | 4,321.00 | 7,112.00 | 8,951.00 | |
Capital Expenditures |
(708.00) | (767.00) | (832.00) | (798.00) | |
| Other line items | |||||
Cash ROIC |
5.80% | 7.48% | 11.54% | 13.60% | |
Accounts Receivable Turnover |
8.98 | 10.30 | 9.46 | 10.24 | |
Accounts Payable Turnover |
11.30 | 13.42 | 11.95 | 11.88 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
36.08 | 27.83 | 33.41 | 35.05 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.09 | (0.01) | 0.01 | 0.10 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.87% | 6.63% | 6.54% | 6.41% | |
Share Based Compensation of Revenue |
0.10% | 0.10% | 0.11% | 0.12% | |
Interest Coverage |
(8.36) | (11.24) | (10.86) | (8.61) | |
Operating CF/Net income |
(0.77) | (0.76) | (1.23) | (1.91) | |
Depreciation/Fixed assets |
0.58 | 0.63 | 0.60 | 0.59 | |
Capex/Depreciation |
(0.56) | (0.60) | (0.66) | (0.64) | |
Revenue per Share |
378.42 | 394.99 | 402.59 | 410.96 | |
Operating CF per Share |
8.27 | 10.32 | 16.14 | 19.74 | |
Capex per Share |
(1.44) | (1.56) | (1.69) | (1.62) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates